Search Articles — Sudonull

Search Results

From other projects

FDA Fast Track for ADC ZW191 against resistant ovarian cancer

https://ymaho.com/fda-fast-track-for-adc-zw191-against-resistant-ovarian-cancer

ADC ZW191 received Fast Track status from FDA for platinum-resistant ovarian cancer. ORR 64%, works with low FRα expression. Learn about the breakthrough and risks.

Trending Now